Combination chemotherapy with 4′Demethylepipodophyllotoxin 9-(4,6-0-ethylidene-β-d-glucopyranoside), VP 16–213 (NSC 141540) in L1210 Leukemia
Authors:
- Per DombernowskyPDPer Dombernowsky
- Nis I. NissenNNNis I. Nissen
- 1 March 1976
- journal article
- research article
- Published by Elsevier
- Vol. 12 (3) , 181-188
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Two epipodophyllotoxin derivatives, VM 26 and VP 16213, in the treatment of leukemias, hematosarcomas, and lymphomasCancer, 1974
- Epipodophyllotoxin VP 16213 in Treatment of Acute Leukaemia—Haematosarcoma and Solid TumoursBMJ, 1973
- The Use of Drugs in Combination for the Treatment of CancerNew England Journal of Medicine, 1973
- Activity of a new glycosidic lignan derivative (VP 16-213) related to podophyllotoxin in experimental tumorsEuropean Journal of Cancer (1965), 1973